Loading…

An Analysis of Immature Platelet Fraction Values

Introduction Immune thrombocytopenia (ITP) in children typically manifests with acute, severe thrombocytopenia leading to variable mucocutaneous and tissue bleeding. Despite gaining insight into disease biology, there is no confirmatory diagnostic test, leaving the clinician to exclude other causes...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2021-11, Vol.138 (Supplement 1), p.3171-3171
Main Authors: Conway, Cicely, Grimes, Amanda B, Despotovic, Jenny M., Kirk, Susan E, Kim, Taylor Olmsted, Huang, Xiaofan, Minard, Charles
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Immune thrombocytopenia (ITP) in children typically manifests with acute, severe thrombocytopenia leading to variable mucocutaneous and tissue bleeding. Despite gaining insight into disease biology, there is no confirmatory diagnostic test, leaving the clinician to exclude other causes of thrombocytopenia through clinical and laboratory findings. The immature platelet fraction (IPF) is determined by hematologic analyzers via platelet size and RNA content and serves as a measure of bone marrow thrombocyte production. A higher value indicates increased thrombopoiesis. While data exists regarding the validity of IPF as a diagnostic tool for differentiating hypo-productive and consumptive etiologies of thrombocytopenia in the adult population, there is a paucity of data regarding its use in the pediatric population. Objectives This study set out to determine how the IPF value may be utilized to support the diagnosis of ITP among pediatric patients. Methods This is a retrospective cohort study at a single tertiary care children's hospital. The electronic medical record (EMR) system was reviewed to include all patients who had an IPF resulted from January 1, 2016 through December 31, 2021. The investigators utilized REDCap ® (Research Electronic Data Capture) to create a database of pediatric patients with thrombocytopenia including their laboratory findings and final diagnoses. Patients were classified as either ITP or non-ITP. Characteristics of ITP and non-ITP cohorts were compared using Wilcoxon rank sum test and Pearson Chi-square test. An ROC-AUC analysis was conducted to identify the IPF value which best predicted if the patient had ITP or not with a 95% confidence interval (CI). The optimal cutoff value was estimated using Youden's index. Sensitivity and specificity were estimated for the cutoff value. Univariable logistic regression was then used to estimate associations between patient characteristics and diagnosis of ITP. Multivariable logistic regression was used to estimate the association between binary IPF and ITP adjusting for other predictors. Statistical significance was assessed at the 0.05 level. Results Demographics shown in Table 1 are stratified by patients who had their IPF within 30 days of diagnosis of thrombocytopenia and those who did not. The IPF was significantly higher at presentation in all patients with ITP than patients without ITP (median IPF 12.8% vs 10.5%, P=0.018). An optimal IPF cutoff point for ITP vs. not ITP
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2021-151956